Roberto Pazo-Cid

Hospital Universitario Miguel Servet ORCID: 0000-0002-8026-7391

1

h-index

1

Publications

2,580

Citations

Publications

1 shown

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian , Kohei Shitara , Markus Moehler +26 more

2021 The Lancet 2580 citations

Frequent Co-Authors

Yelena Y. Janjigian

Memorial Sloan Kettering Cancer Center

Kohei Shitara

National Cancer Center Hospital East

Markus Moehler

Johannes Gutenberg University Mainz

Marcelo Garrido

Pontificia Universidad Católica de Chile

Pamela Salman

Fundación Arturo López Pérez

Lin Shen

Peking University

Researcher Info

h-index: 1
Publications: 1
Citations: 2,580
Institution: Hospital Universitario Miguel Servet

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-8026-7391

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.